Swipe om te navigeren naar een ander artikel
While participation in cancer screening can facilitate early detection and improved prognosis, all screening tests yield some proportion of abnormal test results which are later determined benign. These false positive (FP) results can negatively impact affective, cognitive, and behavioral outcomes. Women participating in an ovarian cancer (OC) screening program receiving an abnormal screening test result (n = 375) were matched with women receiving normal results (n = 375). Both groups completed a baseline and 1- and 4-month follow-up assessments. FP test results were clearly associated with increased cancer-specific distress and increased perceptions of OC risk with more limited evidence for increased perceived positive consequences of screening and increased intentions to participate in future OC screening. FP OC screening test results negatively impact both affective and cognitive outcomes which may serve to reduce motivation to participate in future routine screening. The development and testing of brief, timely interventions to minimize this negative impact is warranted.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50, 179–211. CrossRef
American Cancer Society. (2015). Cancer facts and figures. Atlanta: American Cancer Society.
American Cancer Society. (2016). Cancer facts and figures. Atlanta: American Cancer Society.
Antoni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., et al. (2001). Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20, 20–32. CrossRefPubMed
Barrett, J., Jenkins, V., Farewell, V., Menon, U., Jacobs, I., Kilkerr, J., et al. (2014). Psychological morbidity associated with ovarian cancer screening: Results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS). British Journal of Obstetrics and Gynecology, 121, 1071–1079. CrossRef
Horowitz, M. (1982). Stress response symptoms and their treatment. In L. Goldberger & S. Breznitz (Eds.), Handbook of stress: Theoretical and clinical aspects (pp. 711–732). New York: Free Press.
Jenkins, V., for and on behalf of UKCTOS Trialists, Fallowfield, L., Langridge, C., Barrett, J., Ryan, A., Jacobs, I., Kilkerr, J., Menon, U., & Farewell, V. (2015). Psychological factors associated with withdrawal from the United Kingdom Collaborative Trial of Ovarian Cancer Screening after 1 episode of repeat screening. International Journal of Gyncegological Cancer, 25, 1519–1525.
Moyer, V.A., & U.S. Preventive Services Task Force. (2012). Screening for ovarian cancer: U.S. preventive services task force reaffirmation recommendation statement. Annals of Internal Medicine, 157, 900–904. CrossRef
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582–592. PubMed
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401. CrossRef
Stanton, A. L. (2010). Positive consequences of the experience of cancer: Perception of growth and meaning. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, et al. (Eds.), Psycho-oncology (2nd ed., pp. 547–550). New York: Oxford University Press. CrossRef
Stanton, A. L., Bower, J. E., & Low, C. A. (2006). Posttraumatic growth after cancer. In L. G. Calhoun & R. G. Tedeschi (Eds.), Handbook of posttraumatic growth: Research and practice (pp. 138–175). Mahwah, NJ: Erlbaum.
Tedeschi, R. G., & Calhoun, L. G. (1995). Trauma and transformation: Growing in the aftermath of significant suffering. Newbury Park, CA: Sage Publications. CrossRef
Tedeschi, R. G., & Calhoun, L. G. (2004). Posttraumatic growth: Conceptual foundations and empirical evidence. Psychological Inquiry, 15, 1–18. CrossRef
van Nagell, J. R., & Pavlik, E. J. (2012). Ovarian cancer screening. Clinics in Obstetrics and Gynecology, 55, 43–51. CrossRef
Wardle, J., Pernet, A., Collins, W., & Bourne, T. (1994). False positive results in ovarian cancer screening: One year follow-up of psychological status. Psychology and Health, 10, 33–40. CrossRef
- Affective, cognitive and behavioral outcomes associated with a false positive ovarian cancer screening test result
Amanda T. Wiggins
Edward J. Pavlik
Michael A. Andrykowski
- Springer US